David Albert
About David Albert
David Albert is the Founder and Chief Medical Officer at AliveCor Inc., where he has worked since 2011. He is a physician, inventor, and serial entrepreneur with a strong background in cardiovascular diagnostic devices and a history of founding multiple technology companies.
Work at AliveCor
David Albert serves as the Founder and Chief Medical Officer at AliveCor Inc., a position he has held since 2011. Under his leadership, AliveCor has become known for its innovative contributions to digital health, particularly with the commercialization of the KardiaMobile personal ECG technology. The company is recognized for its clinically validated digital health solutions, which have transformed the way cardiovascular health is monitored. Albert's extensive experience in the medical technology field has been instrumental in guiding the company's strategic direction and product development.
Education and Expertise
David Albert has a robust educational background, having graduated with Honors from Harvard College with a Bachelor of Arts in Government. He furthered his studies at Duke University School of Medicine, where he earned his MD. His expertise lies in cardiovascular diagnostic devices, including ECG, echo, CT, MRI, and nuclear technologies. Albert's academic and professional pursuits have led to significant contributions in the field, including over 100 published abstracts and journal articles, as well as 60 issued US patents.
Background
David Albert is originally from Oklahoma and has built a career as a physician, inventor, and serial entrepreneur. He founded several technology companies, including Corazonix, Lifetone Technology, and InnovAlarm. His early career included roles at GE Medical Systems, where he served as Chief Scientist and General Manager, focusing on wireless systems and cardiology. Albert's entrepreneurial spirit led him to develop life-saving technologies and products over the past three decades.
Achievements
David Albert has achieved notable milestones throughout his career. He played a key role in leading Data Critical to go public on NASDAQ in 1999 before its acquisition by GE Healthcare in 2001. He has authored or co-authored over 50 scientific abstracts and publications, showcasing his contributions to cardiovascular literature. Albert holds 32 issued US patents, reflecting his commitment to innovation in medical technology. His work has significantly impacted the development of new technologies and products in the healthcare sector.